欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2021, Vol. 26 ›› Issue (4): 382-388.doi: 10.12092/j.issn.1009-2501.2021.04.004

• 基础研究 • 上一篇    下一篇

LC-MS/MS法测定人血浆中安立生坦浓度及其药代动力学应用

马红1,2,刘静媛2,金浩3,陈勇3,王博4,刘万卉1,司端运2,5,夏媛媛2,5   

  1. 1烟台大学药学院,烟台 264005,山东;2释药技术与药代动力学国家重点实验室,天津药物研究院,天津 300193;3江苏德源药业有限公司,连云港 222047,江苏;4天津药物研究院药业有限责任公司,天津 300301;5中国医学科学院药物代谢新技术创新单元,天津 300193

  • 收稿日期:2021-01-28 修回日期:2021-04-02 出版日期:2021-04-26 发布日期:2021-05-11
  • 通讯作者: 夏媛媛,女,博士,副研究员,主要从事药物分析和临床药代动力学研究。 Tel: 13302170217 E-mail: xiayy@tipr.com.cn
  • 作者简介:马红,女,硕士研究生在读,研究方向:药物分析与药代动力学研究。 Tel: 13595579953 E-mail: 1913473971@qq.com
  • 基金资助:
    中国医学科学院医学与健康科技创新工程项目资助(2019-I2M-5-020)

Quantification of ambrisentan in human plasma by LC-MS/MS and its pharmacokinetic application

MA Hong 1,2, LIU Jingyuan 2, JIN Hao 3, CHEN Yong 3, WANG Bo 4, LIU Wanhui 1, SI Duanyun 2,5, XIA Yuanyuan 2,5   

  1. 1 School of Pharmacy, Yantai University, Yantai 264005, Shandong, China; 2 State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China; 3 Jiangsu Deyuan Pharmaceutical Co., Ltd, Lianyungang 222047, Jiangsu, China; 4 Tianjin Institute of Pharmaceutical Research Pharmaceutical Co., Ltd, Tianjin 300301, China; 5 Research Unit for Drug Metabolism, Chinese Academy of Medical Sciences, Tianjin 300193, China
  • Received:2021-01-28 Revised:2021-04-02 Online:2021-04-26 Published:2021-05-11

摘要: 目的:建立LC-MS/MS法测定人血浆中安立生坦浓度并应用于人体药代动力学研究。方法:采用液-液萃取法从人血浆中提取安立生坦和内标后,在Waters Symmetry C18柱(4.6 mm×100 mm, 5 μm)上进行色谱分离,有机相:40%甲醇-60%乙腈,水相:5 mmol/L乙酸铵-10%乙腈,流速:0.5 mL/min,电喷雾离子化源,多反应监测,负离子模式,安利生坦和内标的监测离子对分别为m/z 377.1→301.2和m/z 380.4→301.0。结果:安立生坦在2~2 000 ng/mL浓度范围内线性良好,定量下限为2 ng/mL,批内精密度小于2.72%,批间精密度小于8.98%,经内标归一化后的基质效应在92.3%~98.3%之间,提取回收率在74.6%~80.5%之间。 结论:该方法灵敏、经济、可靠,适用于人血浆中安立生坦浓度的测定,满足人体药代动力学研究。

关键词: LC-MS/MS, 安立生坦, 人血浆, 药代动力学

Abstract: AIM: To establish an LC-MS/MS method to determine the concentration of ambrisentan in human plasma and apply it to the study of human pharmacokinetics.  METHODS: After extracting ambrisentan and internal standard from human plasma by liquid-liquid extraction, chromatographic separation was performed on a Waters Symmetry C18 column (4.6 mm×100 mm, 5 μm), organic phase: 40%methanol-60%acetonitrile, water phase: 5 mmol/L ammonium acetate-10% acetonitrile, flow rate: 0.5 mL/min, electrospray ionization source, multi-reaction monitoring, negative ion mode, monitoring ion pairs of ambrisentan and internal standard are m/z 377.1→301.2 and m/z 380.4→301.0, respectively. RESULTS: The linearity of ambrisentan was good in the concentration range of 2-2 000 ng/mL, the lower limit of quantification was 2 ng/mL, the intra-day precision was less than 2.72%, the inter-day precision was less than 8.98%, the matrix effect after normalization by internal standard was between 92.3% and 98.3%, and the extraction recoveries were between 74.6% and 80.5%. CONCLUSION: This method is sensitive, economical, and reliable. It is suitable for the determination of the concentration of ambrisentan in human plasma and meets the requirements of human pharmacokinetic studies.

Key words: LC-MS/MS, ambrisentan,  , human plasma, pharmacokinetics

中图分类号: